Olympus Corporation

Olympus Corporation Overview

Company Headquarters: Japan

Founded: 1919

Workforce: 46,500

Company Working: Olympus Corporation is a Japanese multinational corporation that specializes in manufacturing and selling optical and reprography products, as well as medical and surgical equipment. The company was founded in 1919 and is headquartered in Tokyo, Japan. Olympus Corporation is organized into four main business segments: Medical, Scientific Solutions, Imaging, and Financial. The Medical segment is the largest and most important business segment of the company, accounting for approximately two-thirds of the company's total revenue. The Medical segment includes endoscopy and surgical products, as well as clinical and research microscopes which includes Biopsy devices.

Within the Medical segment, Olympus Corporation offers a range of products for minimally invasive surgical procedures, including endoscopes and endotherapy devices. One of the key products offered by Olympus Corporation is its biopsy device, which is used to collect tissue samples from various parts of the body for diagnostic purposes. Olympus Corporation's biopsy device is designed to be used with endoscopes and comes in a range of sizes and shapes to suit different clinical needs. The company has a global presence with operations in various regions around the world. The company's headquarters is located in Tokyo, Japan, and it has several subsidiaries and offices in different countries.

Strategy

Olympus Corporation is a global technology leader in the medical, scientific, and industrial markets. The company's key strategy is to leverage its advanced technology and strong brand recognition to drive growth through a combination of product innovation, strategic partnerships, and business restructuring. Olympus invests heavily in research and development to create new and innovative products that meet the evolving needs of its customers, while also pursuing strategic partnerships to expand its product offerings and market reach. The company also aims to enhance its operational efficiency and profitability through business restructuring and cost-cutting measures. By executing on these strategic initiatives, Olympus seeks to maintain its competitive edge, enhance customer satisfaction, and deliver sustainable long-term value to its stakeholders.

Company Snapshot

$7,314M

Revenue

46,500

Employees

1919

Founded

Japan

Headquarters

SWOT Analysis

Strengths

Strong global presence
Strong workforce
Strong brand presence around the world of advertising media
Wide product portfolio
Huge workforce
Successful mergers & acquisitions
Strong R&D capabilities
Improving profitability
Strong liquidity
Strong research and development
Strong distribution network
Diversified business portfolio

Weaknesses

Legal issues and product recalls in past years can impact the company’s image
Unable to obtain the licenses and approvals in various countries
Civil litigation filed in the US
Product recall
Heavy reliance on the Medical segment for revenue

Opportunities

Opportunities to increase its market penetration in the healthcare sector
Increasing mergers and acquisitions
Strengthen corporate value
Growing demand of minimally invasive devices in healthcare sector
Focus on strategic partnership and alliance
New product launches
Growing global demand for medical and imaging equipment, particularly in emerging markets

Threats

Growing competition from global market players
Threat of substitution
Increase in counterfeit products
Stringent regulations
Intense competition
Intense Competition

Key Developments

Date	Approach	Development
May 2016	Product Launch	Olympus launched an action camera Stylus TG-Tracker designed to work in any environment. The camera holds features such as waterproof, dustproof, shockproof, and freezeproof.
Sep-2021	Product Launch	Olympus Corporation launched EZ Shot 3 Plus 25 G needle in September 2021. The EZ Shot 3 Plus is a fine needle biopsy device that is designed to obtain high-quality tissue samples with minimal damage to surrounding tissue.
Jan-2021	Product Launch	Olympus Corporation has also been focused on improving the usability and efficiency of its biopsy devices. For example, in January 2021, the company launched its next-generation electrosurgical generator, the ESG-150, which features a range of advanced features to improve safety, performance, and ease of use during endoscopic procedures. The ESG-150 is compatible with a range of Olympus endoscopes and devices, including biopsy forceps and needles.
Oct-2020	Product Launch	Olympus Corporation introduced its EndoJaw disposable biopsy forceps, which offer improved tissue acquisition and reduced contamination risk, as well as greater procedural efficiency and cost-effectiveness.
Oct-2020	Product Launch	Olympus Corporation has been working on the development of robotic systems for endoscopic procedures, including biopsy procedures. In 2019, the company announced the launch of its ENDO-AID robotic system, which is designed to improve the accuracy and efficiency of endoscopic procedures, including biopsies.
Oct-2019	Partnership	Olympus Corporation announced a partnership with AI software developer Ai4gi to develop a system for detecting and diagnosing gastrointestinal (GI) cancers using endoscopic images. The system uses Olympus' endoscopic imaging technology and Ai4gi's AI algorithms to analyze images in real-time and provide clinicians with real-time diagnostic support.

Product Offering

Olympus Corporation
- Vocal Cord

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.